Bill > S1339

This bill provides for increased oversight of entities that provide pharmacy benefit management services on behalf of group health plans and health insurance coverage. Key provisions: - Requires pharmacy benefit managers (PBMs) to disclose detailed information in annual reports to plan sponsors, including data on drug costs, rebates, utilization, and how affiliated pharmacies are used. This reporting aims to improve transparency around PBM practices. - Prohibits PBMs from restricting disclosure of this information to federal agencies or the Comptroller General for enforcement purposes. - Limits "spread pricing" where PBMs charge plans more for drugs than they pay pharmacies, and requires 100% pass-through of rebates and fees to plans. - Establishes an exceptions process for when patients need to bypass a plan's medication step therapy protocol, with timelines for plan responses. - Requires group health plans and insurers to make certain health claims, provider network, and cost information electronically available to enrollees, providers, and authorized third parties. Overall, the bill aims to increase transparency, prohibit certain PBM practices, and improve patient access to drugs through these provisions focused on regulating pharmacy benefit managers.